EIR Catalent Pharma Solutions Dec 2002

Susan Bruederle FDA, Brian Nicholson FDA$595.00 - Available Now

FDA investigators audited the Catalent Pharma Solutions - Woodstock, IL, United States facility and issued inspectional observation (via FDA 483) on 18 Dec 2002.

Product details

  • Category:
  • Inspection end: 18 Dec 2002
  • Location: Woodstock, United States
  • FEI: 1419377
Add To Cart